India Pharma Outlook (@pharma_outlook) 's Twitter Profile
India Pharma Outlook

@pharma_outlook

Pharma Outlook provides the industry experts analysis of the key pressures facing the Pharma Industry in the year ahead

ID: 1483670843402387456

linkhttps://www.indiapharmaoutlook.com/ calendar_today19-01-2022 05:22:08

1,1K Tweet

245 Followers

466 Following

India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Shilpa Medicare Concludes phase 1 trial for volume replacement therapy News: qrcd.org/6W5y #MedicalInterventions #FluidReplacementTherapy #ClinicalStudy #VolumeReplacementTherapy

Shilpa Medicare Concludes phase 1 trial for volume replacement therapy

News: qrcd.org/6W5y

#MedicalInterventions #FluidReplacementTherapy #ClinicalStudy #VolumeReplacementTherapy
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Indian Pharma Sector To play a crucial role in Global Market News: bit.ly/3MvedCY #Indianpharmaceutical #pharmaceuticalindustry #iPHEX #drugmarket

Indian Pharma Sector To play a crucial role in Global Market

News: bit.ly/3MvedCY

#Indianpharmaceutical #pharmaceuticalindustry #iPHEX #drugmarket
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Nxera Pharma To Receive USD $35 Million from Neurocrine Biosciences News: qrcd.org/6YNP Neurocrine Biosciences Nxera Pharma #NeuropsychiatricDisorders #ClinicalTrials #OralMedication #NeurologicalDisorders

Nxera Pharma To Receive USD $35 Million from Neurocrine Biosciences

News: qrcd.org/6YNP

<a href="/neurocrine/">Neurocrine Biosciences</a>
<a href="/NxeraPharma/">Nxera Pharma</a>

#NeuropsychiatricDisorders #ClinicalTrials #OralMedication #NeurologicalDisorders
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

HealthPlix transforms healthcare with AI for doctor-patient conversations News: qrcd.org/6ZK5 Sandeep Gudibanda, Co-Founder & CEO, HealthPlix #SoftwareProviders #DigitalPrescriptions #HealthcareLandscape #HealthcareDigitalTechnologies

HealthPlix transforms healthcare with AI for doctor-patient conversations

News: qrcd.org/6ZK5

<a href="/sgudibanda/">Sandeep Gudibanda</a>, Co-Founder &amp; CEO, <a href="/HealthPlixTech/">HealthPlix</a>

#SoftwareProviders #DigitalPrescriptions #HealthcareLandscape #HealthcareDigitalTechnologies
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

PharmaEssentia and FORUS Therapeutics Partner to Commercialize BESREMi News: qrcd.org/6aEH #BioPharmaceuticalCompany #OncologyMarket #BioPharmaceuticalFirm #FORUSplans #SalesGoals

PharmaEssentia and FORUS Therapeutics Partner to Commercialize BESREMi

News: qrcd.org/6aEH

#BioPharmaceuticalCompany #OncologyMarket #BioPharmaceuticalFirm #FORUSplans #SalesGoals
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study News: qrcd.org/6bFF Lexaria Bioscience #DrugDeliveryTechnology #InjectionDevices #PharmaceuticalIndustry #DehydraTECH

Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study

News: qrcd.org/6bFF

<a href="/LexariaBioCorp/">Lexaria Bioscience</a>

#DrugDeliveryTechnology #InjectionDevices #PharmaceuticalIndustry #DehydraTECH
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Strides Pharma receives US FDA Nod for theophylline ER tablets News: qrcd.org/6cvc Strides Pharma Science Limited #TherapeuticEffects #ChronicLungDiseases #ManufacturingFacilities #TheophyllineERTablets

Strides Pharma receives US FDA Nod for theophylline ER tablets

News: qrcd.org/6cvc

<a href="/strides_pharma/">Strides Pharma Science Limited</a>

#TherapeuticEffects #ChronicLungDiseases #ManufacturingFacilities #TheophyllineERTablets
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

AstraZeneca Completes Clinical Testing of its Carbon Neutral Inhaler News: qrcd.org/6duY Imperial College London AstraZeneca #ClinicalTesting #GlobalWarmingPotential #MedicalInhalers #PharmaceuticalCompanies

AstraZeneca Completes Clinical Testing of its Carbon Neutral Inhaler

News: qrcd.org/6duY

<a href="/imperialcollege/">Imperial College London</a>
<a href="/AstraZeneca/">AstraZeneca</a>

#ClinicalTesting #GlobalWarmingPotential #MedicalInhalers #PharmaceuticalCompanies
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Roche Opens Pharma R & D Center in Basel to advance scientific innovation News: qrcd.org/6elP Roche #ScientificInnovation #MedicalAdvancements #BiotechnologyCompany #PharmaResearch

Roche Opens Pharma R &amp; D Center in Basel to advance scientific innovation

News: qrcd.org/6elP

<a href="/Roche/">Roche</a>

#ScientificInnovation #MedicalAdvancements #BiotechnologyCompany #PharmaResearch
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Bharat Biotech Signs pact with Alopexx for anti-microbial vaccine News: qrcd.org/6faf Dr. Krishna M. Ella, Executive Chairman, Bharat Biotech Daniel Vlock, CEO of Alopexx Enterprises #VaccineManufacturer #BiotechFirm #DrugDiscovery #HealthcareProducts

Bharat Biotech Signs pact with Alopexx for anti-microbial vaccine

News: qrcd.org/6faf

<a href="/DrKrishnaElla/">Dr. Krishna M. Ella</a>, Executive Chairman, <a href="/BharatBiotech/">Bharat Biotech</a> 
Daniel Vlock, CEO of <a href="/AlopexxLLC/">Alopexx Enterprises</a>

#VaccineManufacturer #BiotechFirm #DrugDiscovery #HealthcareProducts
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Quantum Partners with Ingenu CRO for Study on MS Disease Progression News: qrcd.org/6gOl Quantum BioPharma #BiotechnologySolutions #ClinicalStudy #ClinicalTrial #MSDiseaseProgression

Quantum Partners with Ingenu CRO for Study on MS Disease Progression

News: qrcd.org/6gOl

<a href="/QuantumBP/">Quantum BioPharma</a>

#BiotechnologySolutions #ClinicalStudy #ClinicalTrial #MSDiseaseProgression